US Navy sees the light

Article

The US Navy is proceeding with a programme allowing LASIK with IntraLase flap creation in naval aviators.

The US Navy is proceeding with a programme allowing LASIK with IntraLase flap creation in naval aviators. Until this point, PRK has been the preferred method of choice for refractive surgical correction.

Steven Schallhorn, MD of the Naval Medical Center in San Diego, US, speaking at the Hawaiian Eye 2007, discussed how the military has been reluctant to allow LASIK because contrast sensitivity took longer to be recovered postoperatively than after PRK. However, it was noted that there is a slow visual recovery period, of around three months, after PRK, whereas LASIK offers much faster recovery times.

Dr Schallhorn spoke of the technological advancements in LASIK. One large series study comparing conventional to wavefront-guided LASIK found that the addition of wavefront technology results in fewer higher-order corneal aberrations and therefore better postoperative vision. Another study found better quality of vision and faster visual recovery using the IntraLase femtosecond laser for flap creation compared with mechanical microkeratomes.

As a result of theses studies, the US Navy are prepared to begin a cautious programme allowing LASIK with IntraLase on naval aviators.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.